Pheochromocytoma and pregnancy: A deceptive connection

European Journal of Endocrinology

Volumn 166, Issue 2, 2012, Pages 143-150

  Lenders, Jacques W M ^a,b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; ATENOLOL; BETA ADRENERGIC RECEPTOR; CATECHOLAMINE; DOXAZOSIN; ESMOLOL; LABETALOL; METADRENALIN; NICARDIPINE; PHENOXYBENZAMINE; PROPRANOLOL;

ALPHA ADRENERGIC RECEPTOR BLOCKING; BIOASSAY; CATECHOLAMINE BLOOD LEVEL; CATECHOLAMINE URINE LEVEL; CESAREAN SECTION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG SAFETY; DRUG TOLERABILITY; FETUS RISK; HUMAN; HYPERTENSIVE CRISIS; MATERNAL STRESS; MOLECULAR PATHOLOGY; NOSE CONGESTION; NUCLEAR MAGNETIC RESONANCE IMAGING; ORTHOSTATIC HYPOTENSION; PATIENT ASSESSMENT; PATIENT SAFETY; PHEOCHROMOCYTOMA; POSTOPERATIVE COMPLICATION; PREGNANCY; PREGNANCY COMPLICATION; PREOPERATIVE EVALUATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; TACHYCARDIA; TREATMENT INDICATION; TUMOR LOCALIZATION; VAGINAL DELIVERY;

ADRENAL GLAND NEOPLASMS; CATECHOLAMINES; DECEPTION; DELIVERY, OBSTETRIC; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; PHEOCHROMOCYTOMA; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC;

EID: 84856104515     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-11-0528     Document Type: Review

References (61)

1. Lenders JW, Eisenhofer G, Mannelli M & Pacak K. Phaeochromocytoma. Lancet 2005 366 665-675. (doi:10.1016/S0140-6736(05)67139-5)
2. Lo CY, Lam KY, Wat MS & Lam KS. Adrenal phaeochromocytoma remains a frequently overlooked diagnosis. American Journal of Surgery 2000 179 212-215. (doi:10.1016/S0002-9610(00)00296-8)
3. Sutton MG, Sheps SG & Lie JT. Prevalence of clinically unsuspected phaeochromocytoma. Review of a 50-year autopsy series. Mayo Clinic Proceedings 1981 56 354-360. (Pubitemid 11093806)
4. Harrington JL, Farley DR, van Heerden JA & Ramin KD. Adrenal tumours and pregnancy. World Journal of Surgery 1999 23 182-186. (doi:10.1007/ PL00013159)
5. Harper MA, Murnaghan GA, Kennedy L, Hadden DR & Atkinson AB. Phaeochromocytoma in pregnancy. Five cases and a review of the literature. British Journal of Obstetrics and Gynaecology 1989 96 594-606. (doi:10.1111/j.1471-0528. 1989.tb03262.x)
6. Schenker JG & Chowers I. Phaeochromocytoma and pregnancy. Review of 89 cases. Obstetrical and Gynecological Survey 1971 26 739-747. (doi:10.1097/00006254-197111000-00001)
7. Dean RE. Phaeochromocytoma and pregnancy. Obstetrics and Gynecology 1958 11 35-42.
8. Ahlawat SK, Jain S, Kumari S, Varma S & Sharma BK. Phaeochromocytoma ass iated with pregnancy: case report and review of the literature. Obstetrical and Gynecological Survey 1999 54 728-737. (doi:10.1097/00006254-199911000- 00025)
9. Schenker JG & Granat M. Phaeochromocytoma and pregnancy -an updated appraisal. Australian and New Zealand Journal of Obstetrics and Gynaecology 1982 22 1-10. (doi:10.1111/j.1479-828X.1982.tb01388.x)
10. Oishi S & Sato T. Phaeochromocytoma in pregnancy: a review of the Japanese literature. Endocrine Journal 1994 41 219-225. (doi:10.1507/endocrj.41. 219)
11. Sarathi V, Lila AR, Bandgar TR, Menon PS & Shah NS. Phaeochromocytoma and pregnancy: a rare but dangerous combination. Endocrine Practice 2010 16 300-309. (doi:10.4158/EP09191.RA)
12. Natrajan PG, McGarrigle HH, Lawrence DM & Lachelin GC. Plasma noradrenaline and adrenaline levels in normal pregnancy and in pregnancy-induced hypertension. British Journal of Obstetrics and Gynaecology 1982 89 1041-1045. (doi:10.1111/j.1471-0528.1982.tb04661.x)
13. Jaffe RB, Harrison TS & Cerny JC. Localization of metastatic phaeochromocytoma in pregnancy by caval catheterization. Including urinary catecholamine values in uncomplicated pregnancies. American Journal of Obstetrics and Gynecology 1969 104 939-944.
14. Zuspan FP. Urinary excretion of epinephrine and norepinephrine during pregnancy. Journal of Clinical Endocrinology and Metabolism 1970 30 357-360. (doi:10.1210/jcem-30-3-357)
15. Goodall M & Diddle AW. Epinephrine and norepinephrine in pregnancy. A comparative study of the adrenal gland and catechol output in different species of animals and man. American Journal of Obstetrics and Gynecology 1971 111 896-904.
16. Peleg D, Munsick RA, Diker D, Goldman JA & Ben-Jonathan N. Distribution of catecholamines between fetal and maternal compartments during human pregnancy with emphasis on L-dopa and dopamine. Journal of Clinical Endocrinology and Metabolism 1986 62 911-914. (doi:10.1210/jcem-62-5-911)
17. Saarikoski S. Fate of noradrenaline in the human foetoplacental unit. Acta Physiologica Scandinavica. Supplementum 1974 421 1-82.
18. Dahia PL, Hayashida CY, Strunz C, Abelin N & Toledo SP. Low cord blood levels of catecholamine from a newborn of a phaeochromocytoma patient. European Journal of Endocrinology 1994 130 217-219. (doi:10.1530/eje.0.1300217)
19. Bzoskie L, Blount L, Kashiwai K, Tseng YT, Hay WW Jr & Padbury JF. Placental norepinephrine clearance: in vivo measurement and physiological role. American Journal of Physiology 1995 69 E145-E149.
20. Slotkin TA & Seidler FJ. Adrenomedullary catecholamine release in the fetus and newborn: secretory mechanisms and their role in stress and survival. Journal of Developmental Physiology 1988 10 1-16. (Pubitemid 18064101)
21. Oliva R, Angelos P, Kaplan E & Bakris G. Phaeochromocytoma in pregnancy: a case series and review. Hypertension 2010 55 600-606. (doi:10.1161/HYPERTENSIONAHA.109.147579)
22. Burnichon N, Briere JJ, Libe R, Vescovo L, Rivière J, Tissier F, Jouanno E, Jeunemaitre X, Bénit P, Tzagoloff A, Rustin P, Bertherat J, Favier J & Gimenez-Roqueplo AP. SDHA is a tumour suppressor gene causing paraganglioma. Human Molecular Genetics 2010 19 3011-3020. (doi:10.1093/hmg/ ddq206)
23. Mannelli M, Castellano M, Schiavi F, Filetti S, Giacchè M, Mori L, Pignataro V, Bernini G, Giachè V, Bacca A, Biondi B, Corona G, Di Trapani G, Grossrubatscher E, Reimondo G, Arnaldi G, Giacchetti G, Veglio F, Loli P, Colao A, Ambrosio MR, Terzolo M, Letizia C, Ercolino T, Opocher G & Italian Pheochromocytoma/ Paraganglioma Network. Clinically guided genetic screening in a large cohort of italian patients with phaeochromocytomas and/or functional or nonfunctional paragangliomas. Journal of Clinical Endocrinology and Metabolism 2009 94 1541-1547. (doi:10.1210/jc.2008-2419)
24. Qin Y, Yao L, King EE, Buddavarapu K, Lenci RE, Chocron ES, Lechleiter JD, Sass M, Aronin N, Schiavi F, Boaretto F, Opocher G, Toledo RA, Toledo SP, Stiles C, Aguiar RC & Dahia PL. Germline mutations in TMEM127 confer susceptibility to phaeochromocytoma. Nature Genetics 2010 42 229-233. (doi:10.1038/ng.533)
25. Comino-Mendez I, Gracia-Aznarez FJ, Schiavi F, Landa I, Leandro- García LJ, Letón R, Honrado E, Ramos-Medina R, Caronia D, Gómez-Graña A, de Cubas AA, Inglada-Pérez L, Maliszewska A, Taschin E, Bobisse S, Pica G, Loli P, Hernández-Lavado R, Díaz JA, Gómez-Morales M, González-Neira A, Roncador G, Rodríguez- Antona C, Benítez J, Mannelli M, Opocher G, Robledo M & Cascón A. Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma. Nature Genetics 2011 43 663-667. (doi:10.1038/ng.861)
26. Brouwers FM, Eisenhofer G, Lenders JW & Pacak K. Emergencies caused by phaeochromocytoma, neuroblastoma, or ganglioneuroma. Endocrinology and Metabolism Clinics of North America 2006 35 699-724. (doi:10.1016/j.ecl.2006.09. 014)
27. Schurmeyer TH, Engeroff B, Dralle H & von zur Mühlen A. Cardiological effects of catecholamine-secreting tumours. European Journal of Clinical Investigation 1997 27 189-195. (doi:10.1046/j.1365-2362.1997.850646.x)
28. Liao WB, Liu CF, Chiang CW, Kung CT & Lee CW. Cardiovascular manifestations of phaeochromocytoma. American Journal of Emergency Medicine 2000 18 622-625. (doi:10.1053/ajem.2000.7341)
29. Kim J, Reutrakul S, Davis DB, Kaplan EL & Refetoff S. Multiple endocrine neoplasia 2A syndrome presenting as peripartum cardiomyopathy due to catecholamine excess. European Journal of Endocrinology 2004 151 771-777. (doi:10.1530/eje.0.1510771)
30. Ahn JT, Hibbard JU & Chapa JB. Atypical presentation of phaeochromocytoma as part of multiple endocrine neoplasia IIa in pregnancy. Obstetrics and Gynecology 2003 102 1202-1205. (doi:10.1016/S0029-7844(03)00627- 6)
31. Desai AS, Chutkow WA, Edelman E, Economy KE & Dec GW Jr. Clinical problem-solving. A crisis in late pregnancy. New England Journal of Medicine 2009 361 2271-2277. (doi:10.1056/NEJMcps0708258)
32. Keely E. Endocrine causes of hypertension in pregnancy - when to start looking for zebras. Seminars in Perinatology 1998 22 471-484. (doi:10.1016/S0146-0005(98)80027-X)
33. Eisenhofer G, Rivers G, Rosas AL, Quezado Z, Manger WM & Pacak K. Adverse drug reactions in patients with phaeochromocytoma: incidence, prevention and management. Drug Safety 2007 30 1031-1062. (doi:10.2165/00002018-200730110- 00004)
34. Grossman A, Pacak K, Sawka A, Lenders JW, Harlander D, Peaston RT, Reznek R, Sisson J & Eisenhofer G. Biochemical diagnosis and localization of phaeochromocytoma: can we reach a consensus? Annals of the New York Academy of Sciences 2006 1073 332-347. (doi:10.1196/annals.1353.038)
35. Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P, Keiser HR, Goldstein DS & Eisenhofer G. Biochemical diagnosis of phaeochromocytoma: which test is best? Journal of the American Medical Association 2002 287 1427-1434. (doi:10.1001/jama.287.11.1427)
36. Brain KL, Kay J & Shine B. Measurement of urinary metanephrines to screen for phaeochromocytoma in an unselected hospital referral population. Clinical Chemistry 2006 52 2060-2064. (doi:10.1373/clinchem.2006.070805)
37. Lenders JW, Pacak K, Huynh TT, Sharabi Y, Mannelli M, Bratslavsky G, Goldstein DS, Bornstein SR & Eisenhofer G. Low sensitivity of glucagon provocative testing for diagnosis of phaeochromocytoma. Journal of Clinical Endocrinology and Metabolism 2010 95 238-245. (doi:10.1210/jc.2009-1850)
38. Eisenhofer G, Goldstein DS, Walther MM, Friberg P, Lenders JW, Keiser HR & Pacak K. Biochemical diagnosis of phaeochromocytoma: how to distinguish true- from false-positive test results. Journal of Clinical Endocrinology and Metabolism 2003 88 2656-2666. (doi:10.1210/jc.2002-030005)
39. Ilias I, Sahdev A, Reznek RH, Grossman AB & Pacak K. The optimal imaging of adrenal tumours: a comparison of different methods. Endocrine-Related Cancer 2007 14 587-599. (doi:10.1677/ERC-07-0045)
40. Freier DT & Thompson NW. Phaeochromocytoma and pregnancy: the epitome of high risk. Surgery 1993 114 1148-1152. (Pubitemid 24004738)
41. Vanderveen KA, Thompson SM, Callstrom MR, Young WF Jr, Grant CS, Farley DR, Richards ML & Thompson GB. Biopsy of phaeochromocytomas and paragangliomas: potential for disaster. Surgery 2009 146 1158-1166. (doi:10.1016/j.surg.2009.09.013)
42. Plouin PF, Duclos JM, Soppelsa F, Boublil G & Chatellier G. Factors associated with perioperative morbidity and mortality in patients with phaeochromocytoma: analysis of 165 operations at a single center. Journal of Clinical Endocrinology and Metabolism 2001 86 1480-1486. (doi:10.1210/jc.86.4. 1480)
43. Kinney MA,Warner ME, vanHeerden JA, Horlocker TT, Young WF Jr, Schroeder DR, Maxson PM & Warner MA. Perianesthetic risks and outcomes of phaeochromocytoma and paraganglioma resection. Anesthesia and Analgesia 2000 91 1118-1123.
44. Goldstein RE, O'Neill JA Jr, Holcomb GW III, Morgan WM III, Neblett WW III, Oates JA, Brown N, Nadeau J, Smith B, Page DL, Abumrad NN & Scott HW Jr. Clinical experience over 48 years with phaeochromocytoma. Annals of Surgery 1999 229 755-764. (doi:10.1097/00000658-199906000-00001)
45. Burgess GE III. Alpha blockade and surgical intervention of phaeochromocytoma in pregnancy. Obstetrics and Gynecology 1979 53 266-270.
46. Bruynzeel H, Feelders RA, Groenland TH, van den Meiracker AH, van Eijck CHJ, Lange JF, de HerderWW& Kazemier G. Risk factors for hemodynamic instability during surgery for phaeochromocytoma. Journal of Clinical Endocrinology and Metabolism 2010 95 678-685. (doi:10.1210/jc.2009-1051)
47. Boutros AR, Bravo EL, Zanettin G & Straffon RA. Perioperative management of 63 patients with phaeochromocytoma. Cleveland Clinic Journal of Medicine 1990 57 613-617.
48. Santeiro ML, Stromquist C & Wyble L. Phenoxybenzamine placental transfer during the third trimester. Annals of Pharmacotherapy 1996 30 1249-1251.
49. Aplin SC, Yee KF & Cole MJ. Neonatal effects of long-term maternal phenoxybenzamine therapy. Anesthesiology 2004 100 1608-1610. (doi:10.1097/00000542-200406000-00039)
50. Weingarten TN, Cata JP, O'Hara JF, Prybilla DJ, Pike TL, Thompson GB, Grant CS, Warner DO, Bravo E & Sprung J. Comparison of two preoperative medical management strategies for laparoscopic resection of phaeochromocytoma. Urology 2010 76 508-511.
51. Sibal L, Jovanovic A, Agarwal SC, Peaston RT, James RA, Lennard TW, Bliss R, Batchelor A & Perros P. Phaeochromocytomas presenting as acute crises after beta blockade therapy. Clinical Endocrinology 2006 65 186-190. (doi:10.1111/j.1365-2265.2006.02571.x)
52. MacCarthy EP & Bloomfield SS. Labetalol: a review of its pharmacology, pharmacokinetics, clinical uses and adverse effects. Pharmacotherapy 1983 3 193-219. (Pubitemid 13014328)
53. Briggs RS, Birtwell AJ & Pohl JE. Hypertensive response to labetalol in phaeochromocytoma. Lancet 1978 1 1045-1046. (doi:10.1016/S0140-6736(78)90772- 9)
54. Proye C, Thevenin D, Cecat P, Petillot P, Carnaille B, Verin P, Sautier M & Racadot N. Exclusive use of calcium channel blockers in preoperative and intraoperative control of phaeochromocytomas: hemodynamics and free catecholamine assays in ten consecutive patients. Surgery 1989 106 1149-1154. (Pubitemid 20012395)
55. Pacak K. Preoperative management of the phaeochromocytoma patient. Journal of Clinical Endocrinology and Metabolism 2007 92 4069-4079. (doi:10.1210/jc.2007-1720)
56. James MF & Cronje L. Phaeochromocytoma crisis: the use of magnesium sulfate. Anesthesia and Analgesia 2004 99 680-686. (doi:10.1213/01.ANE. 0000133136.01381.52)
57. Mannelli M & Bemporad D. Diagnosis and management of phaeochromocytoma during pregnancy. Journal of Endocrinological Investigation 2002 25 567-571.
58. Yumi H. Guidelines for diagnosis, treatment, and use of laparoscopy for surgical problems during pregnancy: this statement was reviewed and approved by the Board of Governors of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), September 2007. It was prepared by the SAGES Guidelines Committee. Surgical Endoscopy 2008 22 849-861. (doi:10.1007/s00464- 008-9758-6)
59. Fernandez-Cruz L, Taura P, Saenz A, Benarroch G & Sabater L. Laparoscopic approach to phaeochromocytoma: hemodynamic changes and catecholamine secretion. World Journal of Surgery 1996 20 762-768. (doi:10.1007/s002689900116)
60. Amar L, Servais A, Gimenez-Roqueplo AP, Zinzindohoue F, Chatellier G & Plouin PF. Year of diagnosis, features at presentation, and risk of recurrence in patients with phaeochromocytoma or secreting paraganglioma. Journal of Clinical Endocrinology and Metabolism 2005 90 2110-2116. (doi:10.1210/jc.2004-1398)
61. Cammarano WB, Gray AT, Rosen MA & Lim KH. Anesthesia for combined cesarean section and extra-adrenal phaeochromocytoma resection: a case report and literature review. International Journal of Obstetric Anesthesia 1997 6 112-117. (doi:10.1016/S0959-289X(97)80008-8)